Advanced search
Publication Cover
Clinical Toxicology Volume 60, 2022 - Issue 8
Submit an article Journal homepage
348
Views
1
CrossRef citations to date
0
Altmetric
Short Communications

A cluster of 25B-NBOH poisonings following exposure to powder sold as lysergic acid diethylamide (LSD)

Sean T. Ivorya Department of Emergency Medicine, The Northern Hospital, Melbourne, Australia
,
Joe-Anthony Rotellaa Department of Emergency Medicine, The Northern Hospital, Melbourne, Australia;b Victorian Poisons Information Centre, Austin Health, Melbourne, Australia
,
Jennifer Schumannc Victorian Institute of Forensic Medicine, Monash University, Melbourne, Australia
&
Shaun L. Greeneb Victorian Poisons Information Centre, Austin Health, Melbourne, AustraliaCorrespondence[email protected]
Pages 966-969 | Received 02 Jan 2022, Accepted 08 Mar 2022, Published online: 28 Mar 2022

References

  • Shafi A, Berry AJ, Sumnall H, et al. New psychoactive substances: a review and updates. Ther Adv Psychopharmacol. 2020;10:2045125320967197.
  • UNDOC early warning advisory on new psychoactive substances. 2020. [accessed 7 September 2021]. Available from: https://www.unodc.org/LSS/Page/NPS
  • Deen AA, Claridge H, Treble RD, et al. Deaths from novel psychoactive substances in England, Wales and Northern Ireland: evaluating the impact of the UK psychoactive substances act 2016. J Psychopharmacol. 2021;35(11):1315–1323.
  • Zawilska JB, Kacela M, Adamowicz P. NBOMes – highly potent and toxic alternatives of LSD. Front Neurosci. 2020;14:78.
  • Machado Y, Coelho Neto J, Lordeiro RA, et al. Identification of new NBOH drugs in seized blotter papers: 25B-NBOH, 25C-NBOH, and 25E-NBOH. Forensic Toxicol. 2020;38(1):203–215.
  • Eshleman AJ, Wolfrum KM, Reed JF, et al. Neurochemical pharmacology of psychoactive substituted N-benzylphenethylamines: high potency agonists at 5-HT2A receptors. Biochem Pharmacol. 2018;158:27–34.
  • Arantes LC, Júnior EF, de Souza LF, et al. 25I-NBOH: a new potent serotonin 5-HT2A receptor agonist identified in blotter paper seizures in Brazil. Forensic Toxicol. 2017;35(2):408–414.
  • Chia XWS, Ong MC, Yeo YYC, et al. Simultaneous analysis of 2Cs, 25-NBOHs, 25-NBOMes and LSD in seized exhibits using liquid chromatography-tandem mass spectrometry: a targeted approach. Forensic Sci Int. 2019;301:394–401.
  • de Morais DR, Barbosa IL, Cunha KF, et al. EASI-IMS an expedite and secure technique to screen for 25I-NBOH in blotter papers. J Mass Spectrom. 2017;52(10):701–706.
  • Reddit. 2014. NBOMe vs. NBOH. [accessed 14 December 2021]. Available from: https://www.reddit.com/r/Drugs/comments/1wj3v0/nbome_vs_nboh
  • Di Rago M, Pantatan S, Hargreaves M, et al. High throughput detection of 327 drugs in blood by LC-MS-MS with automated data processing. J Anal Toxicol. 2021;45(2):154–183.
  • Mardal M, Andreasen MF, Mollerup CB, et al. HighResNPS.com: an online Crowd-Sourced HR-MS database for suspect and non-targeted screening of new psychoactive substances. J Anal Toxicol. 2019;43(7):520–527.
  • Pasin D, Mollerup CB, Rasmussen BS, et al. Development of a single retention time prediction model integrating multiple liquid chromatography systems: application to new psychoactive substances. Anal Chim Acta. 2021;1184:339035.
  • AIHW. National drug stratergy household survey 2019. Drug statistics series no. 32 PHE 270. Canberra, Australia: Australian Institute of Health and Welfare (AIHW); 2020.
  • Liechti ME. Modern clinical research on LSD. Neuropsychopharmacology. 2017;42(11):2114–2127.
  • Liechti ME. Effects of MDMA on body temperature in humans. Temperature (Austin). 2014;1(3):192–200.
  • Nielsen LM, Holm NB, Leth-Petersen S, et al. Characterization of the hepatic cytochrome P450 enzymes involved in the metabolism of 25I-NBOMe and 25I-NBOH. Drug Test Anal. 2017;9(5):671–679.
  • Breusova K, Ernstsen KG, Palner M, et al. A quantitative method for the selective 5-HT2A agonist 25CN-NBOH in rat plasma and brain. J Pharm Biomed Anal. 2021;199:114016.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.